The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

A new report published in the journal Communications Medicine suggests Pfizer’s (PFE) Paxlovid may help some long Covid patients, but which ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

It is down 13% YTD and 30% in the last 5 years. The stock even missed the weight loss drugs craze as the company doesn’t make such medicine. Amidst this gloom, new investors continue to find the ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercialization rights to giroctocogene fitelparvovec ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% ...

The stock even missed the weight loss drugs craze as the company doesn’t make such medicine. Amidst this gloom ... 80 hedge fund portfolios held PFE at the end of the third quarter which ...